Such findings highlight the role of astrocytes in synaptic defects in DS, and although there are no effective methods to date to prevent or restore such synaptic defects, these results demonstrate the potential of astrocyte-secreted molecules such as TSP-1 as therapeutic targets for symptomatic relief in DS and other neurological disorders associated with synaptic defects. Here, THBS1 is linked to Dravet syndrome.